What is CG Oncology's cash ratio?

CG Oncology (CGON) reported cash ratio of 1× in Q1 2026.

How has CG Oncology's cash ratio changed year-over-year?

CG Oncology's cash ratio decreased by 47.8% year-over-year, from 1.8× to 1×.

What is the long-term trend for CG Oncology's cash ratio?

Over 2 years (2023 to 2025), CG Oncology's cash ratio has grown at a 34.8% compound annual growth rate (CAGR), from 0.6× to 1.1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

CG Oncology CGON Cash ratio

Cash ratio at other companies

PfizerPFE

0.1×0.0×

Johnson & JohnsonJNJ

0.4×-0.3×

Gilead SciencesGILD

0.8×+0.2×

ImmunityBio, Inc.IBRX

3×+1.8×

Cogent Biosciences, Inc.COGT

4.2×+1.6×

Tango TherapeuticsTNGX

11.2×+9.5×

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

cash and equivalents/total current liabilities=1×

Based on the most recent quarter.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's cash ratio?: CG Oncology (CGON) reported cash ratio of 1× in Q1 2026.
How has CG Oncology's cash ratio changed year-over-year?: CG Oncology's cash ratio decreased by 47.8% year-over-year, from 1.8× to 1×.
What is the long-term trend for CG Oncology's cash ratio?: Over 2 years (2023 to 2025), CG Oncology's cash ratio has grown at a 34.8% compound annual growth rate (CAGR), from 0.6× to 1.1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.